May 14, 2018
Dive
Brief:
- Medicare Advantage (MA) payer
Clover Health is starting an in-home primary care program
that includes genomic testing integration to help with medication therapy
management.
- YouScript will provide a clinical
decision support tool to help Clover’s most vulnerable members while
reducing emergency department (ED) visits and hospitalizations.
- About 500 Clover Health members in
New Jersey have joined the program.
Dive
Insight:
Clover
said the voluntary program is being offered at no cost. It includes a
physician-led team with primary care physicians, nurses, social workers,
medical assistants and care coordinators. The program identifies and
addresses “all outstanding and incipient patient concerns, including those
related to medication management.”
Five
percent of Medicare fee-for-service beneficiaries in 2013 drove 42% of annual Medicare FFS
spending.
Care
team members interact with Clover's technology platform, which
uses pharmacogenomic testing to help personalize drug regimens.
The
program includes regularly scheduled personal check-ins, monitoring and home-based
lab and radiology testing.
The
bid is the latest example of an MA payer and healthcare organization looking to
reduce hospitalizations and costs for the most vulnerable patient populations.
Humana, the second largest MA payer, is buying a piece of Kindred Healthcare, a
home health, hospice and community care businesses.
CMS is giving MA plans more
flexibility to offer supplemental benefits to certain beneficiaries. This
greater flexibility lets plans design offerings that go beyond traditional MA
benefits and can include meal delivery and transportation to
non-medical appointments.
Clover
Health, who has received funding from Alphabet, recently reported that it lost $22 million
in 2017, an improvement over the previous year. Clover also
increased its revenue from $184 million to $267 million and expects revenue in
the $330 million range this year.
No comments:
Post a Comment